| Filed On | Filing |
|---|---|
| 14 Nov 2025 | SCHEDULE 13G/A |
| 29 Sep 2025 | 15-12G |
| 22 Sep 2025 | EFFECT |
| 22 Sep 2025 | EFFECT |
| 19 Sep 2025 | SCHEDULE 13D/A |
| 19 Sep 2025 |
Form 4: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other
Disposed of 6,724,000 shares (Tender Offer) ($13.1M) |
| 19 Sep 2025 | SCHEDULE 13D/A |
| 17 Sep 2025 | SCHEDULE 13D/A |
| 17 Sep 2025 |
Form 4: Frazier Life Sciences X, L.p., 10% owner and 4 others
Disposed of 8,552,536 shares (Tender Offer) ($16.7M) |
| 17 Sep 2025 | S-8 POS |
| 17 Sep 2025 | POS AM |
| 17 Sep 2025 | POS AM |
| 17 Sep 2025 |
Form 4: Hershberg Robert, Director
Disposed of 1,101,498 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Cocero Nanette, Director
Disposed of 17,199 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Hilleman Jeryl L, Director
Disposed of 59,224 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Chu Shelley, Director
Disposed of 17,199 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Dubin Gary, Director
Disposed of 17,199 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Kohli Aditya, Director
Disposed of 698,171 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Gerberding Julie L., Director
Disposed of 59,224 shares (Tender Offer) |
| 17 Sep 2025 |
Form 4: Sepulveda Jaime, Director
Disposed of 59,224 shares (Tender Offer) |
Loading...
